The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study

被引:12
作者
Gulati, Swati [1 ,2 ,3 ]
Zouk, Aline N. [1 ,2 ,3 ]
Kalehoff, Jonathan P. [4 ]
Wren, Christopher S. [5 ]
Davison, Peter N. [6 ]
Kirkpatrick, Denay Porter [1 ,2 ,3 ]
Bhatt, Surya P. [1 ,2 ,3 ]
Dransfield, Mark T. [1 ,2 ,3 ,7 ]
Wells, James Michael [1 ,2 ,3 ,7 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA
[3] UAB, Lung Hlth Ctr, Birmingham, AL USA
[4] Univ Alabama Birmingham, Div Internal Med, Birmingham, AL 35294 USA
[5] Auburn Univ, Harrison Sch Pharm, Auburn, AL 36849 USA
[6] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA
[7] Birmingham VA Med Ctr, Birmingham, AL USA
关键词
COPD exacerbation; treatment; corticosteroid; electronic order set; OBSTRUCTIVE PULMONARY-DISEASE; CONTROLLED-TRIAL; MANAGEMENT; COSTS; CARE; READMISSION; DEPRESSION; ADHERENCE; THERAPY; IMPROVE;
D O I
10.2147/COPD.S165665
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Systemic corticosteroids (SC) are an integral part o f managing acute exacerbations of COPD (AECOPD). However, the optimal dose and duration vary widely in clinical practice. We hypothesized that the use of a "PowerPlan" order set in the electronic health system (EHS) that includes a 5-day SC order would be associated with a reduced steroid dose and length of stay (LOS) for individuals hospitalized with AECOPD. Patients and methods: We conducted a retrospective cohort study of Medicare recipients discharged with an AECOPD diagnosis from our University Hospital from 2014 to 2016. Our EHS-based "COPD PowerPlan" order set included admission, laboratory, pharmacy, and radiology orders for managing AECOPD. The default SC option included intravenous methylprednisolone for 24 hours followed by oral prednisone for 4 days. The primary endpoint was the difference in cumulative steroid dose between the PowerPlan and the usual care group. Secondary endpoints included hospital LOS and readmission rates. Results: The 250 patients included for analysis were 62 +/- 11 years old, 58% male, with an FEV I 55.1%+/- 23.6% predicted. The PowerPlan was used in 72 (29%) patients. Cumulative steroid use was decreased by 31% in the PowerPlan group (420 +/- 224 vs 611 +/- 462 mg, P<0.001) when compared with usual care. PowerPlan use was independently associated with decreased LOS (3 days; IQR 2-4 days vs 4 days; IQR 3-6 days, P=0.022) without affecting 30- and 90-day readmission rates. Conclusion: Use of a standardized EHS-based order set to manage AECOPD was associated with a reduction in steroid dose and hospital LOS.
引用
收藏
页码:2271 / 2278
页数:8
相关论文
共 32 条
[1]   Results of a Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions [J].
Bhatt, Surya P. ;
Wells, J. Michael ;
Iyer, Anand S. ;
Kirkpatrick, deNay P. ;
Parekh, Trisha M. ;
Leach, Lauren T. ;
Anderson, Erica M. ;
Sanders, J. Greg ;
Nichols, Jessica K. ;
Blackburn, Cindy C. ;
Dransfield, Mark T. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (05) :643-648
[2]   Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease [J].
Brown, Kirstin E. ;
Johnson, Kara J. ;
DeRonne, Beth M. ;
Parenti, Connie M. ;
Rice, Kathryn L. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (06) :811-815
[3]   COPD exacerbations: definitions and classifications [J].
Burge, S ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :46S-53S
[4]   HAZARDS OF HOSPITALIZATION OF THE ELDERLY [J].
CREDITOR, MC .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :219-223
[5]   Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial [J].
Davies, L ;
Angus, RM ;
Calverley, PMA .
LANCET, 1999, 354 (9177) :456-460
[6]   CORTICOSTEROIDS CONTRIBUTE TO MUSCLE WEAKNESS IN CHRONIC AIR-FLOW OBSTRUCTION [J].
DECRAMER, M ;
LACQUET, LM ;
FAGARD, R ;
ROGIERS, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :11-16
[7]   Hospitalization, restricted activity, and the development of disability among older persons [J].
Gill, TM ;
Allore, HG ;
Holford, TR ;
Guo, ZC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (17) :2115-2124
[8]   Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries [J].
Gudmundsson, G ;
Gislason, T ;
Janson, C ;
Lindberg, E ;
Ulrik, CS ;
Brondum, E ;
Nieminen, MM ;
Aine, T ;
Hallin, R ;
Bakke, P .
RESPIRATORY MEDICINE, 2006, 100 (01) :87-93
[9]  
Halpin David M G, 2006, Proc Am Thorac Soc, V3, P619, DOI 10.1513/pats.200603-093SS
[10]   Pharmacoeconomic evaluation of COPD [J].
Hilleman, DE ;
Dewan, N ;
Malesker, M ;
Friedman, M .
CHEST, 2000, 118 (05) :1278-1285